Last reviewed · How we verify

NCT06661174: EBSDKD

A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy

Recruiting now Last updated 28 October 2024
What this trial tests

trial testing Bariatric surgery in Bariatric Surgeries in 100 participants. Currently enrolling.

Timeline
1 October 2023
Primary endpoint
30 October 2025
30 October 2025

Quick facts

Lead sponsorChina-Japan Friendship Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment100
Start date1 October 2023
Primary completion30 October 2025
Estimated completion30 October 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

China-Japan Friendship Hospital

Who can join

Adults 18 to 65, any sex, with Bariatric Surgeries or Diabetic Nephropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Establish a cohort of diabetic kidney disease(DKD) patients with intensive weight loss treatment to evaluate the impact of intensive weight loss treatment on the renal prognosis of DKD and construct a prediction model for the improvement of renal outcomes after weight loss.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bariatric surgery

Trials testing the same drug.

Other recruiting trials for Bariatric Surgeries

Currently open trials in the same condition.

Other China-Japan Friendship Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06661174.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing